Andrea Giovanni Multari

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

Giuseppe Procopio, Michele Prisciandaro, Roberto Iacovelli et al. · Clinical Genitourinary Cancer · 2018 · 39 citations

Urology, Real-world Data From, Metastatic Renal-cell Carcinoma +7

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study

Edoardo Francini, Fang‐Shu Ou, Stefano Lazzi et al. · Translational Oncology · 2020 · 16 citations · Full text

Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer

Giandomenico Roviello, Roberto Petrioli, Valerio Nardone et al. · Medicine · 2018 · 12 citations · Full text

.The Dof, First-line Therapy, Esophageal Cancer +11

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer

Giandomenico Roviello, Silvia Paola Corona, Andrea Giovanni Multari et al. · Oncotarget · 2018 · 11 citations · Full text